Autistic children mother lodges complaint over emissions from Sanofi Depakine drug plant: Report
Paris: The mother of two autistic children in France has lodged a legal complaint for endangering life after she suspected she was exposed to airborne emissions from Sanofi's Depakine epilepsy drug plant, the Le Monde newspaper reported on Monday.
Melanie S., whose children showed neuro-developmental disorders similar to those observed in children whose mothers took Depakine during pregnancy, has never used the drug but since 2011 she has worked in an office located some 50 metres from the plant in Mourenx, southwest France, the paper said.
Her children were born in 2014 and 2016, according to Le Monde.
She filed the complaint on Nov. 15 "against unknown persons" in connection with emissions from the Sanofi plant, the newspaper said.
Sanofi said it was not aware of the complaint and judicial authorities could not be immediately reached for comment.
Sanofi said in an email to Reuters that the production process of sodium valproate at the Mourenx plant generates airborne emissions for which there was no set threshold until April 2018.
Read also: Sanofi probed for possible market manipulation by French prosecutor: Source
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.